Evaluation of Oncoxin-Viusid® in Head and Neck Cancer

NCT03541772 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Head Cancer Neck

Interventions

DIETARY_SUPPLEMENT: Oncoxin-Viusid®
DIETARY_SUPPLEMENT: Placebo

Sponsor

Catalysis SL